Negative symptoms and neuroleptics in catatonic schizophrenia.

@article{Salokangas2003NegativeSA,
  title={Negative symptoms and neuroleptics in catatonic schizophrenia.},
  author={Raimo K R Salokangas and Teija I Honkonen and Eija Steng{\aa}rd and Anna Maija Koivisto and Jarmo Hietala},
  journal={Schizophrenia research},
  year={2003},
  volume={59 1},
  pages={73-6}
}
The association between neuroleptic treatment and the negative symptom dimension (ND) was evaluated in 1528 schizophrenia patients. In patients receiving more than 820 mg chlorpromazine (CPZ), those with catatonic-type disorder had significantly (p<0.05) higher ND scores than those in any of the other diagnostic subtypes. Even in patients receiving 450 mg CPZ or more, catatonic patients had significantly (p=0.046) higher ND scores than other patients. Patients with catatonic schizophrenia are… CONTINUE READING